Feedback / Questions
lixudebart (ALE.F02) - Alentis Therap
https://pulmonaryfibrosisnews.com/news/lixudebart-ipf-receives-orphan-drug-status-fda/
Luigi Manenti; Steven Nathan
Jun 14, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next